<!DOCTYPE html >
<html lang="en">
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p149" style="overflow: hidden; position: relative; background-color: white; width: 433px; height: 649px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_149{left:411px;top:233px;letter-spacing:-0.1px;}
#t2_149{left:411px;top:78px;letter-spacing:-0.3px;}
#t3_149{left:412px;top:630px;letter-spacing:-0.8px;}
#t4_149{left:82px;top:40px;letter-spacing:-1px;word-spacing:3.1px;}
#t5_149{left:82px;top:56px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#t6_149{left:108px;top:56px;letter-spacing:-1px;word-spacing:-0.1px;}
#t7_149{left:179px;top:56px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#t8_149{left:65px;top:90px;letter-spacing:-1px;}
#t9_149{left:78px;top:90px;letter-spacing:-1px;word-spacing:6.3px;}
#ta_149{left:78px;top:106px;letter-spacing:-1px;}
#tb_149{left:65px;top:123px;letter-spacing:-1px;}
#tc_149{left:78px;top:123px;letter-spacing:-1px;word-spacing:4.2px;}
#td_149{left:78px;top:138px;letter-spacing:-1px;word-spacing:11.1px;}
#te_149{left:78px;top:154px;letter-spacing:-1px;word-spacing:8.1px;}
#tf_149{left:78px;top:169px;letter-spacing:-1px;word-spacing:10.1px;}
#tg_149{left:78px;top:184px;letter-spacing:-1px;word-spacing:-0.1px;}
#th_149{left:65px;top:219px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#ti_149{left:65px;top:237px;letter-spacing:-0.8px;word-spacing:-0.5px;}
#tj_149{left:65px;top:254px;letter-spacing:-1px;word-spacing:-0.1px;}
#tk_149{left:65px;top:271px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#tl_149{left:65px;top:289px;letter-spacing:-1px;}
#tm_149{left:65px;top:304px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#tn_149{left:65px;top:339px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#to_149{left:74px;top:356px;letter-spacing:-1px;word-spacing:-0.1px;}
#tp_149{left:74px;top:374px;letter-spacing:-1px;word-spacing:-0.4px;}
#tq_149{left:74px;top:391px;letter-spacing:-1px;}
#tr_149{left:80px;top:391px;letter-spacing:-0.9px;}
#ts_149{left:80px;top:407px;letter-spacing:-1px;}
#tt_149{left:65px;top:437px;letter-spacing:-0.9px;word-spacing:-0.5px;}
#tu_149{left:74px;top:454px;letter-spacing:-0.9px;word-spacing:-0.2px;}
#tv_149{left:74px;top:472px;letter-spacing:-0.9px;word-spacing:-0.1px;}
#tw_149{left:65px;top:507px;letter-spacing:-0.9px;word-spacing:-0.3px;}
#tx_149{left:74px;top:524px;letter-spacing:-1px;}
#ty_149{left:80px;top:524px;letter-spacing:-1px;word-spacing:3.8px;}
#tz_149{left:197px;top:524px;letter-spacing:-1px;word-spacing:3.8px;}
#t10_149{left:80px;top:539px;letter-spacing:-1px;word-spacing:5.2px;}
#t11_149{left:80px;top:555px;letter-spacing:-1px;word-spacing:-0.1px;}
#t12_149{left:74px;top:572px;letter-spacing:-1px;}
#t13_149{left:80px;top:572px;letter-spacing:-1px;}
#t14_149{left:145px;top:572px;letter-spacing:-0.9px;word-spacing:9.2px;}
#t15_149{left:80px;top:587px;letter-spacing:-1px;word-spacing:5.2px;}

.s1_149{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(156,100,158);
}

.s2_149{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(35,31,32);
}

.s3_149{
	FONT-SIZE: 37.6px;
	FONT-FAMILY: AllerDisplay_lq;
	color: rgb(255,255,255);
}

.s4_149{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed_ix;
	color: rgb(35,31,32);
}

.s5_149{
	FONT-SIZE: 48.9px;
	FONT-FAMILY: Helvetica-Condensed-Bold_j0;
	color: rgb(35,31,32);
}

.t.m0_149{
	-webkit-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-ms-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-moz-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
	-o-transform: matrix(0,-1,1,0,0, 0) scale(0.25);
}

</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts149" type="text/css" >

@font-face {
	font-family: Helvetica-Condensed-Bold_j0;
	src: url("fonts/Helvetica-Condensed-Bold_j0.woff") format("woff");
}

@font-face {
	font-family: AllerDisplay_lq;
	src: url("fonts/AllerDisplay_lq.woff") format("woff");
}

@font-face {
	font-family: Helvetica-Condensed_ix;
	src: url("fonts/Helvetica-Condensed_ix.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg149Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg149" style="-webkit-user-select: none;"><object width="433" height="649" data="149/149.svg" type="image/svg+xml" id="pdf149" style="width:433px; height:649px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div id="t1_149" class="t m0_149 s1_149">O Guia do Jovem Internista </div>
<div id="t2_149" class="t m0_149 s2_149">2016</div>
<div id="t3_149" class="t s3_149">147</div>
<div id="t4_149" class="t s4_149">Clindamicina IV 600mg 6/6h ou 900mg 8/8h ou Oral 450mg 6/6h </div>
<div id="t5_149" class="t s4_149">ou + </div>
<div id="t6_149" class="t s4_149">600mg 8/8h + </div>
<div id="t7_149" class="t s4_149">Primaquina 30mg 1xdia </div>
<div id="t8_149" class="t s4_149">A) </div>
<div id="t9_149" class="t s4_149">Sem sinais de gravidade (pO2 &gt;70 mmHg): terapêutica oral, sem </div>
<div id="ta_149" class="t s4_149">corticoterapia</div>
<div id="tb_149" class="t s4_149">B) </div>
<div id="tc_149" class="t s4_149">Com sinais de gravidade (pO2 &lt; 70 mmHg): via endovenosa, swi-</div>
<div id="td_149" class="t s4_149">tch para oral quando melhoria clínica; associar corticosteróides: </div>
<div id="te_149" class="t s4_149">Prednisona 40 mg oral 2 x dia 5 dias, 40mg dia dos 6-10 dias, </div>
<div id="tf_149" class="t s4_149">20mg dia dos 10 dias até completar os 21 dias de tratamento. </div>
<div id="tg_149" class="t s4_149">Pode-se utilizar metilprednisolona endovenosa.</div>
<div id="th_149" class="t s5_149">• Profilaxia</div>
<div id="ti_149" class="t s5_149">- Primária: </div>
<div id="tj_149" class="t s4_149">CD4+ &lt;200cels/mm3 ou história de candidose orofaríngea</div>
<div id="tk_149" class="t s4_149">CD4+ &lt; 14% ou História de Doença definidora de SIDA </div>
<div id="tl_149" class="t s4_149">CD4+ &gt;200 mas &lt;250 quando é impossível monitorizar CD4+ pelo me-</div>
<div id="tm_149" class="t s4_149">nos de 3-3 meses</div>
<div id="tn_149" class="t s5_149">- Secundária:</div>
<div id="to_149" class="t s4_149">- Todos os doentes com história de Pneumonia por Pneumocistis</div>
<div id="tp_149" class="t s4_149">- Descontinuar quando CD4+ &gt; 200cels durante &gt; 3 meses sob TARV</div>
<div id="tq_149" class="t s4_149">- </div>
<div id="tr_149" class="t s4_149">Se PPJ diagnosticada com CD4+ &gt;200 manter profilaxia secundária </div>
<div id="ts_149" class="t s4_149">independentemente do valor dos CD4.</div>
<div id="tt_149" class="t s4_149">- Esquemas:</div>
<div id="tu_149" class="t s4_149">- SMX+TMP 800mg+160mg 1xdia ou 3xsemana </div>
<div id="tv_149" class="t s4_149">- Alternativa - Atovaquone 1500 mg/dia ou Dapsone 100 mg/dia </div>
<div id="tw_149" class="t s5_149">• Toxoplasma Gondii </div>
<div id="tx_149" class="t s4_149">• </div>
<div id="ty_149" class="t s5_149">Manifestações clínicas:</div>
<div id="tz_149" class="t s4_149">Encefalopatia, meningoencefalite e lesões </div>
<div id="t10_149" class="t s4_149">expansivas. Alterações do estado mental, febre, convulsões, cefa-</div>
<div id="t11_149" class="t s4_149">leia, sinais focais</div>
<div id="t12_149" class="t s4_149">• </div>
<div id="t13_149" class="t s5_149">Diagnóstico: </div>
<div id="t14_149" class="t s4_149">clínica + achados imagiológicos (TC CE ou RM) + </div>
<div id="t15_149" class="t s4_149">detecção de taquizoítos em biópsia cerebral (esta fica restrita aos </div>

<!-- End text definitions -->


</div>
</body>
</html>
